This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Ductus arteriosus (changes after birth)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The ductus arteriosus normally closes within the first 48 hours of life by spasm of muscle within its walls. The patency of the ductus during interuterine life is due to the combined effects of low oxygen partial pressure and locally synthesized prostaglandins.

Following birth, the pulmonary resistance falls and the systemic vascular resistance rise due to cessation of the placental circulation. Hence, aortic pressure exceeds right ventricular pressure. Flow through the ductus reverses for several days, becoming left-to-right.

The increased oxygen partial pressure stimulates muscular contraction within the wall of the vessel. There may be a reduction in synthesis of prostaglandin E. Bradykinin is released by the lungs during their first inflation; this also triggers spasm of the muscle within the walls of the ductus.

After a couple of months, complete closure of the ductus is achieved by proliferation of its intima.

This automatic closure mechanism is less likely to work in very premature babies, those with respiratory distress or those with perinatal asphyxia.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.